BRY Fundamental Analysis - BRI-CHEM CORP

Fundamental Rating

BRY gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 13 industry peers in the Trading Companies & Distributors industry. While BRY seems to be doing ok healthwise, there are quite some concerns on its profitability. BRY has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

BRY had negative earnings in the past year.

In the past year BRY had a positive cash flow from operations.

The reported net income has been mixed in the past 5 years: BRY reported negative net income in multiple years.

In multiple years BRY reported negative operating cash flow during the last 5 years.

1.2 Ratios

BRY has a worse Return On Assets (-5.08%) than 84.62% of its industry peers.

BRY's Return On Equity of -14.48% is on the low side compared to the rest of the industry. BRY is outperformed by 84.62% of its industry peers.

		Industry Rank	Sector Rank
ROA	-5.08%
ROE	-14.48%
ROIC	N/A

ROA(3y)1.89%

ROA(5y)-2.15%

ROE(3y)7.6%

ROE(5y)-2.84%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

With a Gross Margin value of 17.18%, BRY is not doing good in the industry: 69.23% of the companies in the same industry are doing better.

BRY's Gross Margin has been stable in the last couple of years.

The Profit Margin and Operating Margin are not available for BRY so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	17.18%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-4.96%

GM growth 5Y-0.62%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

BRY does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for BRY remains at a similar level compared to 1 year ago.

BRY has more shares outstanding than it did 5 years ago.

Compared to 1 year ago, BRY has an improved debt to assets ratio.

2.2 Solvency

BRY has an Altman-Z score of 1.35. This is a bad value and indicates that BRY is not financially healthy and even has some risk of bankruptcy.

BRY has a worse Altman-Z score (1.35) than 84.62% of its industry peers.

BRY has a debt to FCF ratio of 1.85. This is a very positive value and a sign of high solvency as it would only need 1.85 years to pay back of all of its debts.

Looking at the Debt to FCF ratio, with a value of 1.85, BRY belongs to the top of the industry, outperforming 92.31% of the companies in the same industry.

BRY has a Debt/Equity ratio of 1.11. This is a high value indicating a heavy dependency on external financing.

BRY has a worse Debt to Equity ratio (1.11) than 76.92% of its industry peers.

Although BRY does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.

		Industry Rank	Sector Rank
Debt/Equity	1.11
Debt/FCF	1.85
Altman-Z	1.35

ROIC/WACCN/A

WACC8.4%

2.3 Liquidity

BRY has a Current Ratio of 1.36. This is a normal value and indicates that BRY is financially healthy and should not expect problems in meeting its short term obligations.

With a Current ratio value of 1.36, BRY is not doing good in the industry: 92.31% of the companies in the same industry are doing better.

A Quick Ratio of 0.62 indicates that BRY may have some problems paying its short term obligations.

BRY has a worse Quick ratio (0.62) than 84.62% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.36
Quick Ratio	0.62

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

BRY shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -251.70%.

Looking at the last year, BRY shows a very negative growth in Revenue. The Revenue has decreased by -18.56% in the last year.

The Revenue has been decreasing by -1.96% on average over the past years.

EPS 1Y (TTM)-251.7%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%72.81%

Revenue 1Y (TTM)-18.56%

Revenue growth 3Y11.21%

Revenue growth 5Y-1.96%

Sales Q2Q%-6.85%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

BRY reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BRY is valued a bit more expensive than 76.92% of the companies in the same industry.

Compared to the rest of the industry, the Price/Free Cash Flow ratio of BRY indicates a rather cheap valuation: BRY is cheaper than 100.00% of the companies listed in the same industry.

		Industry Rank	Sector Rank
P/FCF	0.47
EV/EBITDA	22.4

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

BRY does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

BRI-CHEM CORP

TSX:BRY (6/18/2025, 7:00:00 PM)

0.21

-0.01 (-2.33%)

Chartmill FA Rating

GICS SectorIndustrials

GICS IndustryGroupCapital Goods

GICS IndustryTrading Companies & Distributors

Earnings (Last)05-14 2025-05-14

Earnings (Next)08-12 2025-08-12

Inst OwnersN/A

Inst Owner ChangeN/A

Ins Owners7.8%

Ins Owner ChangeN/A

Market Cap5.55M

Analysts0

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.07
P/FCF	0.47
P/OCF	0.46
P/B	0.29
P/tB	0.29
EV/EBITDA	22.4

EPS(TTM)-0.1

EYN/A

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)0.44

FCFY211.5%

OCF(TTM)0.46

OCFY217.81%

SpS3.09

BVpS0.72

TBVpS0.72

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-5.08%
ROE	-14.48%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	17.18%
FCFM	14.38%

ROA(3y)1.89%

ROA(5y)-2.15%

ROE(3y)7.6%

ROE(5y)-2.84%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-4.96%

GM growth 5Y-0.62%

F-Score2

Asset Turnover1.5

Health

		Industry Rank	Sector Rank
Debt/Equity	1.11
Debt/FCF	1.85
Debt/EBITDA	36.42
Cap/Depr	27.48%
Cap/Sales	0.43%
Interest Coverage	N/A
Cash Conversion	2088.29%
Profit Quality	N/A
Current Ratio	1.36
Quick Ratio	0.62
Altman-Z	1.35

F-Score2

WACC8.4%

ROIC/WACCN/A

Cap/Depr(3y)93.13%

Cap/Depr(5y)56.73%

Cap/Sales(3y)1.06%

Cap/Sales(5y)0.65%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-251.7%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%72.81%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-18.56%

Revenue growth 3Y11.21%

Revenue growth 5Y-1.96%

Sales Q2Q%-6.85%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-121.05%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y330.18%

FCF growth 3YN/A

FCF growth 5Y-15.31%

OCF growth 1Y504.32%

OCF growth 3YN/A

OCF growth 5Y-14.89%

BRI-CHEM CORP (BRY.CA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens